Fraunhofer Translational Center Regenerative Therapies TLC-RT
In vitro test system
Preclinical risk and efficacy tests and the development of new products in the chemical industry are currently dependent on animal experiments. As an ethically unproblematic and often more scientifically meaningful alternative, the TLZ-RT develops 3D tissue models that are very close to human tissues morphologically and in terms of their respective functionality.
In addition, we develop new technical approaches, such as process automation or non-invasive testing. Thus, we improve quality and availability of the models or are able to make more accurate statements about the tissue state.
We support our partners in the following areas:
- Pharma
- Cosmetics
- Chemistry
- Medical Devices
- Dental
